We're doing some maintenance on our website between Thursday 9 May 2024 and Monday 13 May 2024. If you encounter any issues accessing our website during this time, you may need to refresh your browser to continue.
Vaxxas – Needle-Free Vaccines
Vaxxas
Vaxxas is disrupting and revolutionizing the way vaccines are delivered, through their innovative Nanopatch™.
The R&D Tax Incentive helped attract further investment in our company and open up more chances for collaboration with large pharma companies, universities and philanthropic organisations around the world.
Company Profile
Company: Vaxxas Pty Ltd
Sector: Biotechnology
Location: Brisbane
Profile: Vaxxas is a medical technology start-up located in Brisbane, revolutionizing the way vaccines are delivered. Vaccinations have historically been given using syringes and needles; however through Research & Development, Vaxxas has been able to develop their Nanopatch – a less invasive vaccine delivery technology that creates a more potent immune response.
We use cookies to give you a better experience on our website. Learn more about how we use cookies and how you can select your preferences.